LabCorp

Hospitals

LabCorp to pay $49.5M to settle Medicaid fraud suit

LabCorp (NYSE:LH) is paying $49.5 million to settle a Medicaid fraud lawsuit claiming the company overcharged California’s Medicaid program and gave doctors medical kickbacks for patient referrals. Burlington, North Carolina-based LabCorp disclosed the proposed settlement payment in a securities filing. During today’s second quarter earnings conference call, LabCorp executives did not discuss the lawsuit or […]

presented by
Pharma

LabCorp’s bid for Clearstone part of global clinical trials strategy

Diagnostics technologies and lab services company LabCorp (NYSE:LH) is acquiring Clearstone Central Laboratories to boost the company’s capabilities and global reach providing services for clinical trials. Burlington, North Carolina-based LabCorp announced the definitive agreement on Wednesday, though the company did not disclose any financial terms of its proposed acquisition of privately held Clearstone. The companies […]

News

DNA testing company Orchid to be acquired by LabCorp for $85M

Diagnostic technologies and genomic testing company LabCorp will buy DNA testing services company Orchid Cellmark in a deal valued at $85.4 million. LabCorp (NYSE:LH) said that the definitive agreement calls for the Burlington, North Carolina-based company to acquire all of the outstanding shares of Orchid (NASDAQ:ORCH) for $2.80 per share. That’s 39 percent more than […]

News

University of Minnesota licenses lupus test to LabCorp

The University of Minnesota has licensed a test for lupus to Laboratory Corporation of America Holdings (NYSE:LH). Developed by Emily Baechler Gillespie, an assistant professor of medicine at the university's medical school, the test can help doctors proactively treat symptoms of lupus, a painful autoimmune disease.

presented by